Strategies for the modification of risk factors in gynecological cancers

Strategies to modify risk for female or gynecological cancers will vary with our knowledge of the epidemiology, etiology, and specific molecular mechanisms for each individual cancer. In general, cancer preventive strategies have been divided into primary and secondary prevention with primary prevention directed toward the causative factors for a disease. Secondary prevention is classically used in cervical cancer cytology screening programs and is essentially an attempt to identify individuals in a population with preclinical phases of the disease where intervention will impact mortality the most. A vast literature has evolved regarding the epidemiology of most of the common cancers in women. While the specific molecular mechanisms are not completely understood at this time knowledge of contributing factors for many of these tumors is well known. The association of cigarette smoking with lung cancer has been well established and the increasing rates of lung cancer, particularly in women, are directly linked to the increasing number of female smokers in the population. Indeed in many western countries lung cancer deaths have overtaken breast cancer as the most common cause of death from malignant disease in women. Excessive sun exposure without adequate skin protection is another lifestyle activity that is related to the high incidence of skin cancer in certain areas. Epidemiologically, cervical cancer has been studied extensively with the current data indicating a causal role of exposure to human papillomavirus (HPV), particularly at an early age in this disease. Hereditary breast and ovarian cancer syndromes are well understood and as more information on human genomics becomes available a clear understanding of the underlying molecular mechanisms of these diseases will be possible and hopefully will result in effective strategies for their control. Unfortunately, in spite of the vast knowledge that is available regarding risk factors for many of these malignancies we have been unable to influence effective lifestyle changes that could substantially reduce the risk of these malignancies in our population. Increased efforts in education, research, and commitment--both financial and educational--are required by governments and other social organizations.

Cancer risk; Gynecological oncology; Human Papillomavirus; Smoking and lung cancer risk

[1] Tobacco Smoking International Agency for Research on Cancer: Monographs on the evaluation of carcinogenic risk to humans Vol 38. Tobacco Smoking. Lyon, TARC, 1986.

[2] Boyle P.: "Cancer, cigarette smoking and premature death in Europe. A review including the recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996". Lung Cancer, 1997, 17, 1.

[3] National Cancer Institute of Canada. Canadian Cancer Statistics 1997. Toronto, Canada, Canadian Cancer Society, 1997.

[4] Boyle P.: "Progress in preventing death from colorectal cancer". Br. J. Cancer, 1995, 72, 528.

[5[ Steinmetz K. A., Potter J. D.: "Vegetable, fruit, and cancer I: epidemiology". Cancer Causes Control., 1991, 2, 325.

[6] Beasley R. P.: "Hepatitis B virus: the major etiology of hepatocellular carcinoma". Cancer, 1988, 61, 1942.

[7] Munoz N., Bosch F. X.: "HPV and cervical neoplasia: review of case-control and cohort 、tudies". International Agency for Research on Cancer Scientific Publications no. 119. Lyon, IARC, 1992.

[8] Haenszel W., Kurihara M.: "Studies of Japanese migrants I: mortality from cancer and other diseases among Japanese in the United States". J. Natl. Cancer Inst., 1968, 40, 43.

[9] McCredie M., Coates M.: "Cancer incidence in migrants to New South Wales". Int. J. Cancer, 1990, 46, 228.

[10] Ewertz M., Duffy S. W., Adami H. 0. et al.: "Age at first birth, parity and risk of breast cancer: a meta-analysis of eight studies from the Nordic countries". Int. J. Cancer, 1990, 46, 597.

[11] Trichopoulos D., Hsieh C. C., MacMahon B. et al.: "Age at any birth and breast cancer risk". Int. J. Cancer, 1983, 31, 701.

[12] Thompson W. D., Janerich D. T.: "Maternal age at birth and risk of breast cancer in daughters". Epidemiology, 1990, 1, 101.

[13] London S. J., Colditz G. A., Stampfer M. J. et al.: "Lactation and risk of breast cancer in a cohort of US women". Am. J. Epide-miol., I 990, 132, 17.

[14] Howe H. L., Senie R. T., Bzduch H.. Herzfeld P.: "Early abortion and breast cancer risk among women under age 40". Int. J. Epidemiol., 1989, 18, 300.

[15] Lipworth L., Katsouyanni K., Ekbom A. et al.: "Abortion and the risk of breast cancer: a case-control study in Greece". Int. J. Cancer, 1995, 6/(Pt 2), 181.

[16] Daling J. R., Brinton L. A., Voigt L. F. et al.: "Risk of breast cancer among white women following induced abortion". Am. J. Epidemiol.. 1996, 144(Pt 4), 373.

[17] Boyd N. F., Martin L. J., Noffel M. et al.: "A meta-analysis of studies of dietary fat and breast cancer ri、k". Br. J. Cancer, 1993, 68, 627.

[18] Hunter D. J., Spiegelman D., Adami H-O. et al.: " Cohort studies of fat intake and the risk of breast cancer - a pooled analysis". N Engl. J. Med., 1996, 334, 356.

[19] Martin-Moreno J. M., Boyle P., Gorgojo L. et al.: "Dietary fat, olive oil intake and breast cancer risk". Int. J. Cancer, 1994, 58, 774.

[20] Trichopolou A., Katsouyanni K., Stuver S. et al.: " Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece"..l. Natl. Cancer Inst., 1995, 87, 110.

[21] La Vecchia C., Negri E., Franceschi S. et al.: "Olive oil, other dietary fats and the risk of breast cancer (Italy)". Cancer Causes Control., 1995, 6, 545.

[22] Collaborative Group on Hormonal Factors in Breast Cancer: "Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 with breast cancer and I 00,239 women without breast cancer from 54 epidemiological studies' Lancet, 1966, 347, 1713.

[23] Prentice R. L., Thomas D. B.: "On the epidemiology of oral contraceptives and disease". Adv. in Cancer Res., 1987, 49, 285.

[24] Hulka B. S., Liu E. T., Lininger R. A.: "Steroid hormones and risk of breast cancer". Cancer, 1994, 74, 1111.

[25] Colditz G. A., Hankinson S. E., Hunter D. J. et al.: "The use of oestrogens and progestins and the risk of breast cancer in postmenopausal women". N. Engl. J. Med., 1995, 332, 1589.

[26] Collaborative Group on Hormonal F actors in Breast Cancer: "Breast cancer and hormone replacement therapy". Lancet, 1997, 350, 1047

[27] Munoz N., Bosch F. X., Jensen 0. M. (eds.): "Human papillomavirus and cervical cancer". International Agency for Research on Cancer Scientific Publication、no. 94, Lyon, IARC, 1989.

[28] Vonka V., Kanka J., Roth Z.: "Herpes simplex type 2 virus and cervical neoplasia". Adv. Cancer Res., 1987, 48, 149.

[29] Brinton L.A., Fraumeni J. F. Jr.: "Epidemiology of uterine cervical cancer". J. Chron. Dis., 1986, 39, 1051.

[30] Brinton L.A., Hamman R. F., Huggins G. R. et al.: "Sexual and reproductive risk factors for invasive squamous cell cervical cancer". J. N atl. Cancer Inst., 1987, 79, 23.

[31] International Agency for Research on Cancer, Working Group on Evaluation of Cervical Screening Programmes: "Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies". Br. Med. J., 1986, 293, 659.

[32] Grady D., Gebretsadik T., Kerlikowski K., Ernster Y., Petitti D.: "Hormone replacement therapy and endometrial cancer risk: a meta-analysis“ Ohstet. Gynecol., 1995, 85, 304.

[33] The Writing Committee for The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial: "Effects of hormone replacement therapy on endometrial histology in post-menopaus al women". J. Am. Med. Assoc., 1996, 275, 370.

[34] Persson I., Adami H-0., Berkvist L.: "Risk of endometrial cancer after treatment with ostrogens alone or in conjunction with progestogens: results of a prospective study". Br. Med. J ., 1989, 298, 1476.

[35] Calle E. E., Miracle-McMahilI H. L., Thun M. J.. Heath C. W.: " Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women". J. Natl. Cancer Inst., 1995, 87, 517.

[36] Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development:' The reduction in risk of ovarian cancer associated with oral-contraceptive use". N. Engl. J. Med., 1987, 316, 650.